In this study, we successfully applied, for the first time, noninvasive in vivo optical imaging to detect prostate cancer in an orthotopic mouse model using a fluorescent-labeled anti-PSMA antibody fragment scFvD2B. This evidence concerns the gene FOLH1 and prostate carcinoma.